Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01040416 · ClinicalTrials.gov registry record
Endoscopic Therapy for Bleeding Marginal Ulcers After Gastric Bypass
A clinical trial of Bleeding Marginal Ulcer, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT01040416: Completed study of Bleeding Marginal Ulcer, sponsored by University of California, San Francisco.
NCT01040416 is a study of Bleeding Marginal Ulcer that has completed, run by University of California, San Francisco. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01040416, a study of Bleeding Marginal Ulcer, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to identify the incidence rate; describe the risk factors, clinical presentation, and endoscopic treatment; assess the morbidity, mortality, and overall performance of the management of patients with actively bleeding marginal ulcers after Roux-en-Y gastric bypass (RYGB) surgery.
Conditions Studied
Study Locations (1)
California
- UCSF Fresno Center for Medical Education and Research - Fresno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-12 |
What the finished NCT01040416 record still lists
NCT01040416 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 1 condition, with Bleeding Marginal Ulcer appearing as the primary indexed condition, and to 0 interventions.
NCT01040416 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01040416 about?
NCT01040416 is a clinical study titled "Endoscopic Therapy for Bleeding Marginal Ulcers After Gastric Bypass". The objective of this study is to identify the incidence rate; describe the risk factors, clinical presentation, and endoscopic treatment; assess the morbidity, mortality, and overall performance of the management of patients with actively bleeding marginal ulcers after Roux-en-Y gastric bypass (RYG...
What is the current status of trial NCT01040416?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2008-12. Estimated completion is 2009-12.
What conditions does trial NCT01040416 study?
This clinical trial studies the following conditions: Bleeding Marginal Ulcer.
Who is sponsoring clinical trial NCT01040416?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01040416 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia